Sleep diagnostics specialist Onera raises 30 million euros for scale-up

Onera Health has raised 30 million euros for the roll-out of its sleep diagnosis and monitoring technology. The Eindhoven-based Imec spin-off helps doctors and researchers remotely monitor people with sleep disorders. The company plans to use the new funding to accelerate the approval of its second-generation so-called polysomnography system (PSG) in Europe and the US. Its ambition is to become a leader in home monitoring for sleep medicine.

EQT Life Sciences and Flemish investment company Gimv are the major backers. Representatives of both these outfits will join Onera’s management board. Previous investors Innovation Industries, Invest-NL, Imec.xpand, BOM and 15th Rock also participated in the new funding round. These parties earlier contributed 25 million euros.

Ruben de Francisco, founder and CEO of Onera Health, says he’s pleased “that two leading life sciences investors” have confidence in his company. “We’ll continue to invest aggressively in R&D and geographic expansion,” he comments. Onera currently has 60 employees and operates in the US, Germany and the Netherlands.